[Managing myocardial infarct in general practice].
Bonassin
F
F
Klinik für Kardiologie, Universitätsspital Zürich.
Wyss
C
C
Schneemann
M
M
D054058:Acute Coronary Syndrome / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D000465:Algorithms; D000789:Angina, Unstable / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D000925:Anticoagulants / Q000008:administration & dosage; D000069059:Atorvastatin; D001774:Blood Chemical Analysis; D002637:Chest Pain / Q000209:etiology; D000077144:Clopidogrel; D017023:Coronary Angiography; D004359:Drug Therapy, Combination; D004502:Education, Medical, Continuing; D004569:Electroencephalography; D005194:Family Practice / Q000193:education; D006493:Heparin / Q000008:administration & dosage; D006538:Heptanoic Acids / Q000008:administration & dosage; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011379:Prognosis; D011758:Pyrroles / Q000008:administration & dosage; D012307:Risk Factors; D013557:Switzerland; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives
D000925:Anticoagulants; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D006493:Heparin; D000069059:Atorvastatin; D000077144:Clopidogrel; D013988:Ticlopidine